SANDS CAPITAL MANAGEMENT SC13G 12-31-2015 (EDWARDS LIFESCIENCES CORP)

Company

Edwards Lifesciences Corp

Filed

February 16, 2016

Accession Number

0001140361-16-052441

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →